Condition: Glaucoma · Ocular Surface Disease · Sponsor: University of California, Los Angeles
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
This description comes directly from the study's public registry record.
Benjamin B Bert, MD · 626-817-4701 · BBert@mednet.ucla.edu
Mayra Raygoza · 16268174747 · Mraygoza@mednet.ucla.edu
Always discuss trial participation with your own doctor first.
| Doheny Eye Center UCLA | Fountain Valley, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04354545